News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Kang-Korea Alcohol Nominees Overwhelmingly Defeated at Dong-A Pharmaceutical (000640KS) EGM
October 31, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SEOUL, South Korea--(BUSINESS WIRE)--Dong-A Pharmaceutical Co Ltd (000640 KS) announced today that all of the dissident Kang-Korea Alcohol nominees for election as director were overwhelmingly defeated at the October 31 EGM.
Twitter
LinkedIn
Facebook
Email
Print
Asia
MORE ON THIS TOPIC
China
Lilly Pumps $3B Into China To Boost Supply of Weight Loss Pill
March 11, 2026
·
2 min read
·
Tristan Manalac
Collaboration
Roche Broadens Global Clinical Trial Footprint With $480M+ South Korea Pledge
March 5, 2026
·
1 min read
·
Tristan Manalac
Immunology and inflammation
Sanofi Bets Up to $1.53B in Hong Kong Immuno Pact, Adding to String of Deals
March 4, 2026
·
2 min read
·
Tristan Manalac
Startups
Harbour Cofunds Cancer Startup, Hands Off Clinical-Stage Antibody
February 25, 2026
·
2 min read
·
Tristan Manalac